Kestrel Group Reports Second Quarter 2026 Financial Results

Go back to Kestrel Group Reports Second Quarter 2026 Financial Results
KING PHARMACEUTICALS (NASDAQ: KG) Delayed: 7.60 -0.29 (3.68%)
Previous Close $7.89    52 Week High $14.26 
Open $7.74    52 Week Low $7.18 
Day High $8.01    P/E 22.35 
Day Low $7.51    EPS $0.34 
Volume 12,932